kabutan

RIKEN VITAMIN CO.,LTD., First Half Ordinary Profit Decreases by 8%

Wed Nov 13, 2024 4:00 pm JST Earnings

4526 RIKEN VITAMIN CO.,LTD. 【J-GAAP】

Earnings Report

RIKEN VITAMIN CO.,LTD. <4526> [TSE-P] announced its financial results after the market closed on November 13th (16:00). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2025 (April to September) decreased by 8.3% from the same period last year to 4.78 billion yen. However, The progress rate against the 9 billion yen full-year plan was 53.2%, also surpassing the five-year average of 49.8%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the October to March period (second half) is expected to decrease by 17.0% from the same period last year to 4.21 billion yen.

In the most recent three-month period, from July to September (2Q), the consolidated ordinary profit decreased to 1.85 billion yen, a 16.3% decrease compared to the same period last year. The operating profit margin worsened from 9.5% in the same period last year to 8.9%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 43,631 3,557 4,149 3,146 95.9 53.7 Nov 11, 2022 J-GAAP
Apr - Sep, 2023 44,613 4,596 5,220 3,667 111.7 50.7 Nov 10, 2023 J-GAAP
Apr - Sep, 2024 47,149 4,626 4,786 3,255 107.2 53.2 Nov 13, 2024 J-GAAP
YoY +5.7% +0.7% -8.3% -11.2% -4.0%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 Guidance 45,500 4,000 4,300 3,300 108.7 40.50 May 10, 2024 J-GAAP
Apr - Sep, 2024 Results 47,149 4,626 4,786 3,255 107.2 40.50 Nov 13, 2024 J-GAAP
Revision Rate +3.6% +15.7% +11.3% -1.4% -1.4%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 46,871 4,775 5,076 5,088 156.0 50.50 May 10, 2024 J-GAAP
Oct - Mar, 2024 Guidance 45,351 3,874 4,214 4,845 162.2 40.50 Nov 13, 2024 J-GAAP
YoY -3.2% -18.9% -17.0% -4.8% +4.0%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 88,750 7,158 7,723 6,414 195.5 59 May 12, 2023 J-GAAP
Mar, 2024 91,484 9,371 10,296 8,755 268.4 81 May 10, 2024 J-GAAP
Mar, 2025 Guidance 92,500 8,500 9,000 8,100 271.1 81 May 10, 2024 J-GAAP
YoY +1.1% -9.3% -12.6% -7.5% +1.0%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 22,424 2,120 2,222 1,599 48.7 9.5 Nov 10, 2023 J-GAAP
Oct - Dec, 2023 24,445 3,064 3,176 2,413 73.5 12.5 Feb 9, 2024 J-GAAP
Jan - Mar, 2024 22,426 1,711 1,900 2,675 82.0 7.6 May 10, 2024 J-GAAP
Apr - Jun, 2024 23,626 2,522 2,927 2,370 78.1 10.7 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 23,523 2,104 1,859 885 29.2 8.9 Nov 13, 2024 J-GAAP
YoY +4.9% -0.8% -16.3% -44.7% -40.2%

Related Articles